Top Infusion Therapy Companies

Global Infusion Therapy Market size was valued at USD 47.43 Billion in 2024 and is poised to grow from USD 50.61 Billion in 2025 to USD 85.02 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026–2033). 

The global infusion therapy market is highly competitive, with several large and small players operating in the market. These companies are the major players in the global infusion therapy market and are focused on expanding their market share through product innovation, partnerships, and strategic acquisitions. 'Option Care Health Inc. (United States) ', 'Baxter International Inc. (United States) ', 'ICU Medical, Inc. (United States) ', 'B. Braun Melsungen AG (Germany) ', 'Terumo Corporation (Japan) ', 'Moog Inc. (United States) ', 'Fresenius SE & Co. KGaA (Germany) ', 'Smiths Medical (United Kingdom) ', 'JMS Co. Ltd. (Japan) ', 'Caesarea Medical Electronics (Israel) ', 'CareFusion Corporation (United States) ', 'Poly Medicure Limited (India) ', 'Nipro Corporation (Japan) ', 'Medtronic plc (Ireland) ', 'Becton, Dickinson and Company (BD) (United States) ', '3M Company (United States) ', 'Teleflex Incorporated (United States) ', 'Edwards Lifesciences Corporation (United States) ', 'Coloplast A/S (Denmark) ', 'Convatec Group plc (United Kingdom) '

The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases has led to an increase in the demand for infusion therapy products and services.

Growing demand for home infusion therapy: There is an increasing trend towards home-based healthcare services, including home infusion therapy. Patients prefer to receive infusion therapy at home rather than in a hospital or clinical setting, as it provides greater convenience, comfort, and cost savings.

North America is the largest market for infusion therapy globally, accounting for a significant share of the global market. One of the key drivers of the infusion therapy market in North America is the high prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. According to the American Cancer Society, an estimated 1.9 million new cancer cases were diagnosed in the United States in 2021. These patients often require infusion therapy for the management of their conditions, leading to a high demand for infusion therapy products and services. In addition, the region has a well-established healthcare infrastructure, with a large number of hospitals, clinics, and other healthcare facilities that offer infusion therapy services. The availability of advanced healthcare technologies, skilled healthcare professionals, and favorable reimbursement policies has further fueled the growth of the market in the region. Furthermore, the increasing trend of home healthcare and the availability of advanced home infusion therapy products and services have also contributed to the growth of the market in North America. Home infusion therapy allows patients to receive their treatments in the comfort of their homes, which can improve patient outcomes and reduce hospital readmissions. Overall, the North America market for infusion therapy is expected to continue its growth trajectory in the coming years, driven by the high prevalence of chronic diseases, well-established healthcare infrastructure, and increasing adoption of home healthcare.